Search

everythinglearnresearchcommunity

for

Search:↓

CL22209, an Asparagus racemosus extract, safely reduces perimenopausal symptoms and balances hormones.

Progesterone and related compounds may help control seizures linked to the menstrual cycle but have limitations that need addressing.

Both new medications and non-drug treatments can effectively manage migraines with fewer side effects.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

Long-term Finasteride treatment reduces depression better than short-term treatment in rats.

Finasteride and dutasteride may cause depression and anxiety, especially in younger men.

Clomipramine may significantly reduce hair-pulling in Trichotillomania, but more research is needed on treatments and early onset cases.

People with early psychosis eat more calories, saturated fat, and sugar, and the drug olanzapine may lead to eating even more calories.

Finasteride affects young male rats' brain function and behavior negatively.

Cognitive-behavioral therapy is the best treatment for hair-pulling disorder, and combining it with other therapies could improve results.

Neurosteroids help protect the brain and improve behavior after a stroke in mice.

A compound named ZCZ90 can increase muscle spindle firing, potentially helping treat muscle spasms and hypertension.

Finasteride may help some male chronic pelvic pain patients, but more research needed.

New drug uses show promise but need more research.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

Epristeride's metabolism involves key metabolites and proteins, affecting its use in doping tests.

The conclusion is that a new method can measure caffeine and drugs in hair, finding caffeine abusers have 70 times more caffeine than normal, with a proposed cut-off value for abuse.

Dutasteride makes alcohol less sedating and may lead to less drinking in men.

Benzo[c]quinolizin-3-ones are effective nonsteroidal inhibitors of human steroid 5α-reductase 1.

Block and replace therapy improved symptoms in recurrent cyclic Cushing’s disease.

4-azasteroids, including finasteride, can inhibit 5α-reductase, helping treat conditions like enlarged prostate and hair loss.

Finasteride treats enlarged prostate and hair loss, but may cause side effects in some patients.

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

20(S)-Protopanaxadiol-aglycone may help prevent and treat prostate cancer by reducing androgen receptor activity.

Some drugs have gained approval for new uses, while others like tricyclic antidepressants and aspirin show promise but aren't yet approved for these uses.